End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.07 USD | +0.88% | -5.70% | +7.48% |
May. 08 | Oculis Holding AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 24 | H.C. Wainwright Adjusts Price Target on Oculis Holding to $28 From $29, Keeps Buy Rating | MT |
Business Summary
Number of employees: 36
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products and Substances
100.0
%
| - | - | 1 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Riad Sherif
CEO | Chief Executive Officer | 56 | 17-11-30 |
Sylvia Cheung
DFI | Director of Finance/CFO | 50 | 20-08-31 |
Ramin Tadayoni
CTO | Chief Tech/Sci/R&D Officer | 54 | Feb. 27 |
Rebecca Weil
PRN | Corporate Officer/Principal | - | 23-09-10 |
Bastian Dehmel
PRN | Corporate Officer/Principal | 54 | 21-12-31 |
Páll Jóhannesson
PRN | Corporate Officer/Principal | 44 | - |
Virginia R. Dean
HRO | Human Resources Officer | 58 | Feb. 27 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 18-03-31 | |
Director/Board Member | 69 | 23-03-02 | |
Director/Board Member | 58 | 23-03-02 | |
Lionel Carnot
BRD | Director/Board Member | 56 | 17-11-30 |
Director/Board Member | 59 | 23-03-02 | |
Pravin Dugel
BRD | Director/Board Member | 60 | 20-03-31 |
Riad Sherif
CEO | Chief Executive Officer | 56 | 17-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 41,649,705 | 38,633,278 ( 92.76 %) | 0 | 92.76 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.48% | 503M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- OCS Stock
- Company Oculis Holding AG